   "); bodyStart = html.indexOf("
   ") + 10; bodyEnding = html.indexOf(""); if (titleStart > 0 && titleEnd
   > 0 && urlStart > 0 && urlEnd > 0 && nameStart > 0 && nameEnding > 0 &&
   bodyStart > 0 && bodyEnding > 0) { //title = html.substring(titleStart,
   titleEnd); title = html.substring(nameStart, nameEnding); bodyTxt =
   html.substring(bodyStart, bodyEnding).toString(); bodyTxt =
   bodyTxt.replace(regex1, ""); bodyTxt = bodyTxt.replace(regex2, ""); url
   = html.substring(urlStart, urlEnd);
   //document.getElementById("entitle").innerHTML = title + "
   Read More"; document.getElementById("entitle").innerHTML = "

   "+"

   " + bodyTxt + "

   " + "

   Read More

   " + "

   Click to close

   "; var container2012 = $( "#container2012" ); container2012.slideDown(
   1000 ); } setTimeout(checkEmergencyNotification, 60000); } function
   closewindow() { jQuery(function( $ ) { $.cookie("notified", true, {
   path: "/" }, { expires: 1 }); // Get a reference to the container var
   container2012 = $( "#container2012" ); container2012.slideUp( 1000 );
   }); } window.onload = function() { checkEmergencyNotification(); };

   Print Profile Print Profile

   jerry.chipuk@mssm.edu

   B.S., Baldwin-Wallace College

   Ph.D., Case Western Reserve University

   Postdoctoral Training, La Jolla Institute for Allergy and Immunology

   Postdoctoral Training, St. Jude Children‚s Research Hospital

   2015 - 2019
   Research Award
   Irma T. Hirschl / Monique Weill-Caulier Research Trusts

   2015 - 2018
   Research Scholar Grant
   American Cancer Society

   2014 -
   Dr. Harold and Golden Lamport Research Award

   2013 - 2016
   Basil O'Connor Phase-In Award
   March of Dimes

   2012 - 2014
   Young Scientist Cancer Research Fund
   JJR Foundation

   2011 - 2013
   Basil O'Connor Award
   March of Dimes

   2003 - 2006
   Ruth Kirschstein NRSA
   National Institutes of Health

   Serasinghe MN, Weider SY, Renault TT, Elkholi R, Asciolla JJ, Yao JL,
   Jabado O, Hoehn K, Kageyama Y, Sesaki H, Chipuk JE. Mitochondrial
   division is requisite to RAS-induced transformation and targeted by
   oncogenic MAPK pathway inhibitors. Molecular Cell 2015 Feb;.

   Renault TT, Floros KV, Elkholi R, Corrigan KA, Kushnareva Y, Wieder SY,
   Lindtner C, Serasinghe MN, Asciolla JJ, Buettner C, Newmeyer DD, Chipuk
   JE. Mitochondrial shape governs BAX-induced membrane permeabilization
   and apoptosis. Molecular Cell 2015 Jan 8; 57(1): 69-82.

   Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam
   D, Alnemri ES, Altucci L, Andrews D, Annicchiarico-Petruzzelli M,
   Baehrecke EH, Bazan NG, Bertrand MJ, Bianchi K, Blagosklonny MV,
   Blomgren K, Borner C, Bredesen DE, Brenner C, Campanella M, Candi E,
   Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA,
   Ciechanover A, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin
   KM, Di Daniele N, Dixit VM, Dynlacht BD, El-Deiry WS, Fimia GM, Flavell
   RA, Fulda S, Garrido C, Gougeon ML, Green DR, Gronemeyer H, Hajnoczky
   G, Hardwick JM, Hengartner MO, Ichijo H, Joseph B, Jost PJ, Kaufmann T,
   Kepp O, Klionsky DJ, Knight RA, Kumar S, Lemasters JJ, Levine B,
   Linkermann A, Lipton SA, Lockshin RA, L√≥pez-Ot√n C, Lugli E, Madeo F,
   Malorni W, Marine JC, Martin SJ, Martinou JC, Medema JP, Meier P,
   Melino S, Mizushima N, Moll U, Mu√±oz-Pinedo C, Nu√±ez G, Oberst A,
   Panaretakis T, Penninger JM, Peter ME, Piacentini M, Pinton P, Prehn
   JH, Puthalakath H, Rabinovich GA, Ravichandran KS, Rizzuto R, Rodrigues
   CM, Rubinsztein DC, Rudel T, Shi Y, Simon HU, Stockwell BR, Szabadkai
   G, Tait SW, Tang HL, Tavernarakis N, Tsujimoto Y, Vanden Berghe T,
   Vandenabeele P, Villunger A, Wagner EF, Walczak H, White E, Wood WG,
   Yuan J, Zakeri Z, Zhivotovsky B, Melino G, Kroemer G. Essential versus
   accessory aspects of cell death: recommendations of the NCCD 2015. Cell
   Death and Differentiation 2015 Jan; 22(1): 58-73.

   Elkholi R, Renault TT, Serasinghe MN, Chipuk JE. Putting the pieces
   together: How is the mitochondrial pathway of apoptosis regulated in
   cancer and chemotherapy. Cancer & Metabolism 2014 Sept; 2(16): 1-15.

   Renault TT, Elkholi R, Bharti A, Chipuk JE. BH3 mimetics demonstrate
   differential activities dependent upon the functional repertoire of
   pro- and anti-apoptotic BCL-2 family proteins. Journal of Biological
   Chemistry 2014 Sept; 289(38): 26481-26491.

   Chong RA, Wu K, Spratt DE, Yang Y, Lee C, Nayak J, Xu M, Elkholi R,
   Tappin I, Li J, Hurwitz J, Brown BD, Chipuk JE, Chen ZJ, Sanchez R,
   Shaw GS, Huang L, Pan ZQ. Pivotal role for the ubiquitin Y59-E51 loop
   in lysine 48 polyubiquitination. Proc Natl Acad Sci USA 2014 June 10;
   111(23): 8434-9.

   Serasinghe MN, Missert DJ, Asciolla JJ, Podgrabinska S, Wieder SY,
   Izadmehr S, Belbin G, Skobe M, Chipuk JE. Anti-apoptotic BCL-2 proteins
   govern cellular outcome following BRAFV600E inhibition and can be
   targeted to reduce resistance. Oncogene 2014 Mar 10;.

   Zhang X, Lv H, Zhou Q, Elkholi R, Chipuk JE, Reddy MV, Reddy EP, Gallo
   JM. Preclinical pharmacological evaluation of a novel multiple kinase
   inhibitor, ON123300, in brain tumor models. Molecular Cancer
   Therapeutics 2014 May; 13(5): 1105-16.

   Lopez-Rivera E, Jayaraman P, Parikh F, Davies MA, Ekmekcioglu S,
   Izadmehr S, Milton DR, Chipuk JE, Grimm EA, Estrada Y, Aguirre-Ghiso
   JA, Sikora AG. Inducible nitric oxide synthase drives mTOR pathway
   activation and proliferation of human melanoma by reversible
   nitrosylation of TSC2. Cancer Research 2014 Feb 15; 74(4): 1067-1078.

   Elkholi R, Chipuk JE. How do I kill thee? Let me count the ways: p53
   regulates PARP-1 dependent necrosis. BioEssays 2014 Jan; 36(1): 46-51.

   Renault TT, Chipuk JE. Death upon a kiss: mitochondrial outer membrane
   composition and organelle communication govern sensitivity to
   BAK/BAX-dependent apoptosis. Chemistry & Biology 2014 Jan 16; 21(1):
   114-123.

   Fink MY, Chipuk JE. Survival of HER2-positive breast cancer cells:
   receptor signaling to apoptotic control centers. Genes & Cancer 2013
   May 8; 4(5-6): 187-195.

   Renault TT, Floros KV, Chipuk JE. BAK/BAX activation and cytochrome c
   release assays using isolated mitochondria. Methods 2013 June; 61(2):
   146-155.

   Beverly LJ, Howell LA, Hernandez-Corbacho M, Casson L, Chipuk JE,
   Siskind LJ. BAK activation is necessary and sufficient to drive
   ceramide synthase-dependent ceramide accumulation following inhibition
   of BCL2-like proteins. The Biochemical Journal 2013 May 15; 452(1):
   111-9.

   Renault TT, Chipuk JE. Getting away with murder: how do the BCL-2
   family of proteins kill with immunity?. Annals of the New York Academy
   of Science 2013 May; 1285(1): 59-79.

   Follis AV, Chipuk JE, Fisher JC, Yun MK, Grace CR, Nourse A, Baran K,
   Ou L, Min L, White SW, Green DR, Kriwacki RW. PUMA binding induces
   partial unfolding within BCL-xL to disrupt p53 binding and promote
   apoptosis. Nature Chemical Biology 2013 Mar; 9(3): 163-8.

   Renault TT, Chipuk JE. Inter-organellar communication with mitochondria
   regulates both the intrinsic and extrinsic pathways of apoptosis.
   Communicative & Integrative Biology 2013 March/April; 6(2): 1-4.

   Anvekar RA, Asciolla JJ, Lopez-Rivera E, Floros KV, Izadmehr S, Elkholi
   R, Belbin G, Sikora AG, Chipuk JE. Sensitization to the mitochondrial
   pathway of apoptosis augments melanoma tumor cell responses to
   conventional chemotherapeutic regimens. Cell Death and Disease 2012 Nov
   15; 3(e420): 1-11.

   Asciolla JJ, Renault TT, Chipuk JE. Examining BCL-2 family function
   with large unilamellar vesicles. Journal of Visualized Experiments 2012
   Oct 5; 68: 1-6.

   Greter M, Helft J, Chow A, Hashimoto D, Mortha A, Agudo-Cantero J,
   Bogunovic M, Gautier EL, Miller J, Leboeuf M, Lu G, Aloman C, Brown BD,
   Pollard JW, Xiong H, Randolph GJ, Chipuk JE, Frenette PS, Merad M.
   GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is
   dispensable for the differentiation of inflammatory dendritic cells.
   Immunity 2012 Jun; 36(6): 1031-46.

   Chipuk JE, McStay GP, Bharti A, Kuwana T, Clarke CJ, Siskind LJ, Obeid
   LM, Green DR. Sphingolipid metabolism cooperates with BAK and BAX to
   promote the mitochondrial pathway of apoptosis. Cell 2012 March;
   148(5): 988-1000.

   Garrison SP, Phillips DC, Jeffers JR, Chipuk JE, Parsons MJ, Rehg JE,
   Opferman JT, Green DR, Zambetti GP. Genetically defining the mechanism
   of PUMA- and BIM-induced apoptosis. Cell Death and Differentiation 2012
   Apr; 18(4): 642-9.

   Elkholi R, Floros KV, Chipuk JE. The role of BH3-Only proteins in tumor
   cell development, signaling, and treatment. Genes & Cancer 2011 May;
   2(5): 523-37.

   Anvekar RA, Asciolla JJ, Missert DJ, Chipuk JE. Born to be alive: a
   role for the BCL-2 family in melanoma tumor cell survival, apoptosis,
   and treatment. Frontiers in Molecular Oncology 2011 Oct; 1(34).

   Du H, Wolf J, Schafer B, Moldoveanu T, Chipuk JE, Kuwana T. BH3 domains
   other than BIM and BID can directly activate BAX/BAK. The Journal of
   Biological Chemistry 2011 Jan; 286(1): 491-501.

   McAuley JL, Chipuk JE, Boyd KL, Van De Velde N, Green DR, McCullers JA.
   PB1-F2 proteins from H5N1 and 20th century pandemic influenza viruses
   cause immunopathology. PLoS Pathogens 2010; 6(7).

   Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, Green DR. The BCL-2
   family reunion. Molecular Cell 2010 Feb; 37(3): 299-310.

   Chipuk JE, Green DR. PUMA cooperates with direct activator proteins to
   promote mitochondrial outer membrane permeabilization and apoptosis.
   Cell Cycle 2009 Sep; 8(17): 2692-6.

   Chipuk JE, Green DR. How do BCL-2 proteins induce mitochondrial outer
   membrane permeabilization? . Trends in Cell Biology 2008 April; 18(4):
   157-164.

   Cassidy-Stone A, Chipuk JE, Ingerman E, Song C, Yoo C, Kurth MJ,
   Hinshaw J, Shaw J, Green DR, Nunnari J. Mitochondrial division
   inhibitors reveal the role of the mitochondrial division dynamin in
   BAX/BAK-dependent mitochondrial cytochrome c release. Developmental
   Cell 2008 February; 14(2): 193-204.

   Green D, Chipuk J. Stabbed in the BAX. Nature 2008 October; 455(7216):
   1047-1049.

   Chipuk JE, Fisher JC, Dillon CP, Kuwana T, Kriwacki RW, Green DR.
   Mechanism of apoptosis induction by the inhibition of BCL-2 proteins.
   Proceedings of the National Academy of Science - USA 2008 Dec; 105(51):
   20327-20332.

   Chipuk JE, Green DR. Do inducers of apoptosis trigger
   caspase-independent cell death?. Nature Reviews Molecular Cellular
   Biology 2005 March; 6(3): 268-275.

   Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, Green DR.
   BH3 domains of BH3-only proteins differentially regulate BAX-mediated
   membrane permeabilization both directly and indirectly. Molecular Cell
   2005 Feb; 17(4): 525-35.

   Chipuk JE, Bouchier-Hayes L, Newmeyer DD, Green DR. PUMA couples the
   nuclear and cytoplasmic pro-apoptotic function of p53. Science 2005
   Sept; 309(5741): 1732-1735.

   Spierings D, McStay GP, Saleh M, Bender C, Chipuk JE, Maurer U, Green
   DR. Connected to death: the (unexpurgated) mitochondrial pathway of
   apoptosis. Science 2005 Oct; 310(5745): 66-67.

   Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler
   M, Green DR. Direct activation of BAX by p53 mediates mitochondrial
   outer membrane permeabilization and apoptosis. Science 2004 Feb;
   303(5660): 1010-1014.

   Chipuk JE, Maurer U, Green DR, Schuler M. Pharmacologic activation of
   p53 elicits BAX-dependent apoptosis in the absence of transcription.
   Cancer Cell 2003 Nov; 4(5): 371-381.

   Physicians and scientists on the faculty of the Icahn School of
   Medicine at Mount Sinai often interact with pharmaceutical, device and
   biotechnology companies to improve patient care, develop new therapies
   and achieve scientific breakthroughs. In order to promote an ethical
   and transparent environment for conducting research, providing clinical
   care and teaching, Mount Sinai requires that salaried faculty inform
   the School of their relationships with such companies.

   Dr. Chipuk did not report having any of the following types of
   financial relationships with industry during 2014 and/or 2015:
   consulting, scientific advisory board, industry-sponsored lectures,
   service on Board of Directors, participation on industry-sponsored
   committees, equity ownership valued at greater than 5% of a publicly
   traded company or any value in a privately held company. Please note
   that this information may differ from information posted on corporate
   sites due to timing or classification differences.

   Mount Sinai's faculty policies relating to faculty collaboration with
   industry are posted on our website. Patients may wish to ask their
   physician about the activities they perform for companies.

   Edit profile in Sinai Central

   Icahn Medical Institute Floor 15 Room 15-20E
   1425 Madison Avenue
   New York, NY 10029
file:///var/folders/07/q1dxpd8s56s0tfqh7n6xv3rm0000gn/T/"%20+%20url%20+%20"
file:///var/folders/07/q1dxpd8s56s0tfqh7n6xv3rm0000gn/T/"%20+%20url%20+%20"
file:///var/folders/07/q1dxpd8s56s0tfqh7n6xv3rm0000gn/T/L49502-9921TMP.html
javascript:window.print()
mailto:jerry.chipuk@mssm.edu
http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook
http://sinaicentral.mssm.edu/
